Xcopri
My Prescription
Payment
Select pharmacy
$1,212.83
Print or send this coupon to your phone
AlbertsonsPowered byAbout Xcopri
Drug Details
Xcopri (cenobamate) is a medication prescribed for the treatment of partial-onset seizures in adults. Although the exact mechanism of action is not fully understood, it is believed to function by influencing sodium and gamma-aminobutyric acid (GABA) channels in brain cells, which helps to reduce electrical activity and the frequency of seizures. This antiepileptic drug is administered orally once daily. To minimize potential side effects such as sleepiness, dizziness, and fatigue, treatment begins with a low dose that is gradually increased over several weeks to the recommended level. As Xcopri is a controlled substance, there may be limitations on prescription refills. Always consult with healthcare professionals before starting this or any medication.
Price history for Xcopri
30 Tablets, 200MG
Average retail price for Xcopri
Average SaveHealth price for Xcopri
Our price history data is based on aggregated prescription data collected from participating pharmacies in America. Our prescription data updates daily to reflect the latest price changes. If you notice a missing data point, it means there wasn't sufficient data available to generate a monetary value for that date.
*Retail prices are based on pharmacy claims data, and may not be accurate when we don't have enough claims.
Xcopri dosage forms
| Dosage | Quantity | Price from | Per unit |
|---|---|---|---|
| 25MG | 30 Tablets | $1,213.51 | $40.45 |
| 50MG | 30 Tablets | $1,212.19 | $40.41 |
| 100MG | 30 Tablets | $1,212.72 | $40.42 |
| 150MG | 30 Tablets | $1,212.82 | $40.43 |
| 200MG | 30 Tablets | $1,213.03 | $40.43 |
Xcopri FAQs
Xcopri is used for the treatment of partial-onset seizures in adults with epilepsy.
Xcopri (cenobamate) and Keppra (levetiracetam) are both medications used to treat seizures, but they are not the same. They belong to different classes of antiepileptic drugs and have different mechanisms of action. While both are used to manage epilepsy, their specific uses, side effects, and interactions may vary. It is important for patients to consult with their healthcare provider to determine which medication is most appropriate for their condition.
Xcopri (cenobamate) is classified as a controlled substance because it has the potential for abuse and dependence. The U.S. Drug Enforcement Administration (DEA) has placed it in Schedule V, indicating a lower potential for abuse compared to substances in Schedules I-IV, but still requiring regulation to prevent misuse.
The success rate of Xcopri (cenobamate) can vary depending on the individual and the specific condition being treated. In clinical trials, Xcopri has been shown to significantly reduce the frequency of seizures in patients with partial-onset seizures. Approximately 20-30% of patients achieved a 50% or greater reduction in seizure frequency, and some patients experienced complete seizure freedom. However, individual responses can vary, and it is important for patients to discuss their specific situation with their healthcare provider.
Cenobamate is not classified as a narcotic. It is an anticonvulsant medication used to treat partial-onset seizures in adults.